Royce & Associates LP lifted its stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 5.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 213,179 shares of the business services provider's stock after buying an additional 10,198 shares during the period. Royce & Associates LP owned about 0.42% of Exponent worth $17,280,000 at the end of the most recent reporting period.
Several other hedge funds have also made changes to their positions in EXPO. KLP Kapitalforvaltning AS bought a new stake in shares of Exponent in the fourth quarter valued at about $1,631,000. LPL Financial LLC lifted its stake in Exponent by 16.0% during the fourth quarter. LPL Financial LLC now owns 69,873 shares of the business services provider's stock worth $6,226,000 after purchasing an additional 9,658 shares during the period. Vanguard Group Inc. lifted its stake in Exponent by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 5,345,503 shares of the business services provider's stock worth $476,284,000 after purchasing an additional 67,296 shares during the period. WINTON GROUP Ltd lifted its stake in Exponent by 2.9% during the fourth quarter. WINTON GROUP Ltd now owns 11,590 shares of the business services provider's stock worth $1,033,000 after purchasing an additional 322 shares during the period. Finally, AssuredPartners Investment Advisors LLC bought a new position in Exponent during the fourth quarter worth about $382,000. Institutional investors own 92.37% of the company's stock.
Insider Activity
In other news, VP Joseph Rakow sold 1,573 shares of Exponent stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $77.72, for a total value of $122,253.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Bradley A. James sold 2,694 shares of Exponent stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $79.52, for a total transaction of $214,226.88. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 6,267 shares of company stock worth $489,120. Insiders own 1.60% of the company's stock.
Exponent Stock Down 0.7%
EXPO traded down $0.54 during midday trading on Monday, reaching $71.70. 47,547 shares of the company's stock were exchanged, compared to its average volume of 304,126. The firm has a market capitalization of $3.64 billion, a price-to-earnings ratio of 34.97 and a beta of 0.90. Exponent, Inc. has a one year low of $71.29 and a one year high of $115.75. The business has a 50-day simple moving average of $75.56 and a two-hundred day simple moving average of $80.90.
Exponent (NASDAQ:EXPO - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The business services provider reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. Exponent had a net margin of 18.87% and a return on equity of 25.33%. The firm had revenue of $137.44 million during the quarter, compared to analysts' expectations of $134.63 million. During the same quarter last year, the company earned $0.59 earnings per share. The company's revenue for the quarter was up .2% compared to the same quarter last year. As a group, research analysts anticipate that Exponent, Inc. will post 1.98 EPS for the current fiscal year.
Exponent Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, June 20th. Stockholders of record on Friday, June 6th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.67%. The ex-dividend date of this dividend was Friday, June 6th. Exponent's dividend payout ratio (DPR) is currently 58.54%.
About Exponent
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Read More

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.